ArticleClinical trials (London, England)2022

Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).

Daniel D Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.